Investigating the Utility of Explainable Artificial Intelligence for Neuroimaging‐Based Dementia Diagnosis and Prognosis
Artificial intelligence and neuroimaging enable accurate dementia prediction but often involve 'black box' models that can be difficult to trust. Explainable artificial intelligence (XAI) aims to provide insights into the model's decisions; however, choosing the most appropriate method is non-trivial and often context-specific. We used T1-weighted MRI to train models on two tasks: Alzheimer's disease (AD) classification (diagnosis) and predicting conversion from mild-cognitive impairment (MCI) to all-cause dementia (prognosis). We applied eleven XAI methods across two popular image classification architectures, producing visualisations of the most salient regions. We also propose a framework for interpreting explanations produced by different XAI methods and predictive models. Models achieved balanced accuracies of 81% and 67% for diagnosis and prognosis. XAI outputs highlighted brain regions relevant to AD with strong convergence across gradient-based techniques. LIME produced explanations that were most similar across architectures. Mean saliency enhanced MCI prognosis prediction when included as an additional input feature. XAI can be used to verify that models are utilising relevant features and to generate valuable measures for further analysis.
Authors
- Jiongqi Qu
- Phoebe Imms (ORCID: https://orcid.org/0000-0002-7205-4177)
- Sophie Martin (ORCID: https://orcid.org/0000-0003-3819-1634)
- Andrei Irimia
- An Zhao
- Alzheimer's Disease Neuroimaging Initiative
- Frederik Barkhof
- James H. Cole
Institutions
- University of Southern California (US)
- King's College London (GB)
- The London College (GB)
- National Hospital for Neurology and Neurosurgery (GB)
- Amsterdam University Medical Centers (NL)
- University College London (GB)
- University of Amsterdam (NL)
Publication Details
- Journal
- Human Brain Mapping
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1002/hbm.70456
- Primary Topic
- Explainable Artificial Intelligence (XAI)
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Defense
- Foundation for the National Institutes of Health
- Alzheimer's Association
- Bristol-Myers Squibb
- Eli Lilly and Company
- Biogen
- University of Southern California
- F. Hoffmann-La Roche
- Alzheimer's Disease Neuroimaging Initiative
- BioClinica
- Northern California Institute for Research and Education
- National Institute for Health and Care Research
- University College London
- Eisai
- IXICO
- National Institutes of Health
- Genentech
- Center for Undergraduate Research and Scholarship, Bowling Green State University
- Canadian Institutes of Health Research
- Engineering and Physical Sciences Research Council
- National Institute on Aging
- National Institute of Biomedical Imaging and Bioengineering